Retinopathy of Prematurity (ROP) Treatment: Examination and Close Follow-up

Mashreq Center's ROP follow-up protocol for premature infants. When is follow-up sufficient, and when is injection or intervention required?

Retinopathy of Prematurity (ROP): Accurate Examination and Follow-up

Retinopathy of Prematurity (ROP) is a significant medical challenge for ophthalmologists, especially those specializing in retina surgery and treatment. This condition, affecting the developing blood vessels in the retina of premature infants, demands extreme vigilance and precise examination and follow-up protocols to ensure early intervention and prevent severe complications that could lead to permanent vision loss. At Al Mashreq Eye Center in Cairo, we fully understand the sensitivity of this condition and the importance of implementing a meticulous treatment and follow-up plan. Dr. Mahmoud Hassan, a key contributor to providing the highest levels of specialized care, ensures this comprehensive approach.

Understanding the nature of Retinopathy of Prematurity (ROP) begins with recognizing that the retina does not fully develop until the final weeks of pregnancy. Therefore, infants born very prematurely are at a higher risk of developing this condition. In such cases, normal blood vessel growth ceases, and abnormal blood vessels develop instead. These abnormal vessels can be fragile and prone to bleeding, leading to retinal damage and detachment.

Why are Early Screening and Accurate Follow-up the Cornerstone of ROP Treatment?

The secret to successful management of Retinopathy of Prematurity (ROP) lies in the ability to detect early signs of the disease before it progresses. Regular and comprehensive retinal examinations are the only way to identify at-risk infants or those who have begun to show signs of the disease. Screening protocols are based on the infant's gestational age at birth and weight, in addition to other risk factors.

Key factors that necessitate early screening include:

• Birth before 31 weeks of gestation.

• Birth weight less than 1500 grams.

• Prolonged need for oxygen.

• Family history of retinal diseases.

• Presence of other health issues associated with prematurity.

The examination is typically performed by a specialized ophthalmologist using an ophthalmoscope after dilating the pupil. This may require repeated examinations at specific intervals, according to a precise schedule determined by the treating physician. This timeline is crucial for follow-up, as it allows for accurate tracking of the condition's progression and determination of whether therapeutic intervention is necessary.

When is Follow-up Sufficient, and When is Intervention Required?

Not all cases of Retinopathy of Prematurity (ROP) require immediate treatment. In the early stages, the physician may opt for close monitoring to observe the condition's development. However, there are warning signs and advanced stages that necessitate rapid intervention to prevent vision loss. These stages include:

• Stage 3: Where abnormal blood vessel growth becomes evident and extensive.

• Plus Disease: An indication of dilated and tortuous blood vessels in the posterior part of the eye, suggesting worsening of the condition.

• Advanced ROP: Which can lead to retinal detachment.

In these cases, the infant is directed towards specific treatment options aimed at halting the growth of abnormal blood vessels and preventing further damage. These options include:

Available Treatments for Retinopathy of Prematurity (ROP)

Al Mashreq Eye Center, under the supervision of Dr. Mahmoud Hassan, offers the latest available treatment options for patients with Retinopathy of Prematurity (ROP), with a focus on achieving the best possible outcomes:

• Laser Photocoagulation: This treatment is one of the oldest and most effective methods. It involves using a laser to destroy abnormal blood vessels in the peripheral parts of the retina that are not functioning well. This reduces abnormal growth signals and prevents the disease from spreading to other areas of the retina.

• Intravitreal Injections: In some advanced cases, specific medications, such as anti-vascular endothelial growth factor (Anti-VEGF) agents, may be injected directly into the vitreous humor of the eye. These medications help to shrink abnormal blood vessels and inhibit their growth. Lucentis is one such medication used in this context and has demonstrated significant efficacy in many cases. Other modern treatment options like Vabysmo are also available.

• Surgery: In advanced cases of retinal detachment, surgery may be necessary. Surgical procedures include vitrectomy to remove blood and scar tissue, and reattaching the retina. These surgeries are complex and require high expertise, which is a specialized area of our team at Al Mashreq Eye Center.

The Importance of Post-Treatment Follow-up

Our role does not end with treatment. Meticulous post-treatment follow-up is crucial to ensure the stability of the condition and prevent relapse. Infants may require regular examinations for several months or even years after treatment to ensure that abnormal blood vessel growth does not recur or other complications such as retinal detachment or glaucoma (high eye pressure) do not develop. Adherence to the follow-up schedule determined by the physician is key to preserving vision as much as possible.

Managing Retinopathy of Prematurity (ROP) requires the concerted efforts of a specialized medical team, advanced equipment, and strict adherence to examination and follow-up protocols. At Al Mashreq Eye Center, we are committed to providing the best possible care for our children, and we work diligently to ensure a bright visual future for them. If your child is a premature infant, do not hesitate to consult our retina specialist to ensure they receive the necessary examination and follow-up.

For more information on eye health and advanced surgeries, you can follow Dr. Mahmoud Hassan's YouTube channel: .

For appointments and inquiries: 01002310813

Articles You Might Enjoy Reading

• Optimal Intraocular Lens Types Post-Cataract Surgery and Their Advantages

• Latest Dye-Free Retinal Imaging Devices: UWF-OCTA Technology at Mashreq Center

https://drmahmoud-hassaan.com/en/articles/retinopathy-of-prematurity-rop-screening-followup